Por favor, use este identificador para citar o enlazar este ítem:
https://www.arca.fiocruz.br/handle/icict/62532
Tipo
ArtículoDerechos de autor
Acceso abierto
Colecciones
- INI - Artigos de Periódicos [3460]
- IOC - Artigos de Periódicos [12642]
- PE - IAM - Artigos de Periódicos [1085]
Metadatos
Mostrar el registro completo del ítem
DETECTION AND PERSISTENCE OF ZIKA VIRUS IN BODY FUIDS AND ASSOCIATED FACTORS: A PROSPECTIVE COHORT STUDY
ZIKV persistence in body fuids
ZIKV RNA recurrent detection
Factors associated with ZIKV persistence
Autor
Calvet, Guilherme Amaral
Kara, Edna Oliveira
Bôtto‑Menezes, Camila Helena Aguiar
Castilho, Marcia da Costa
Franca, Rafael Freitas de Oliveira
Habib, Ndema
Menezes Neto, Armando
Pereira, Gerson Fernando Mendes
Giozza, Silvana Pereira
Bermúdez, Ximena Pamela Díaz
Fernandes, Tatiana Jorge
Modjarrad, Kayvon
Brasil, Patrícia
Broutet, Nathalie Jeanne Nicole
Filippis, Ana Maria Bispo de
Kara, Edna Oliveira
Bôtto‑Menezes, Camila Helena Aguiar
Castilho, Marcia da Costa
Franca, Rafael Freitas de Oliveira
Habib, Ndema
Menezes Neto, Armando
Pereira, Gerson Fernando Mendes
Giozza, Silvana Pereira
Bermúdez, Ximena Pamela Díaz
Fernandes, Tatiana Jorge
Modjarrad, Kayvon
Brasil, Patrícia
Broutet, Nathalie Jeanne Nicole
Filippis, Ana Maria Bispo de
Afiliación
Oswaldo Cruz Foundation. Evandro Chagas National Institute of Infectious Diseases. Acute Febrile Illnesses Laboratory. Rio de Janeiro, RJ, Brazil.
Department of Sexual and Reproductive Health and Research. World Health Organization. Geneva, Switzerland.
Tropical Medicine Foundation Doctor Heitor Vieira Dourado. Department of Malaria. Manaus, AM, Brazil / Amazonas State University. School of Health Sciences. Manaus, AM, Brazil.
Tropical Medicine Foundation Doctor Heitor Vieira Dourado. Department of Malaria. Manaus, AM, Brazil.
Oswaldo Cruz Foundation. Institute Aggeu Magalhães. Department of Virology and Experimental Therapy. Recife, PE Brazil.
Department of Sexual and Reproductive Health and Research. World Health Organization. Geneva, Switzerland.
Oswaldo Cruz Foundation. Institute Aggeu Magalhães. Department of Virology and Experimental Therapy. Recife, PE, Brazil.
Ministry of Health. Department of HIV/AIDS, Tuberculosis, Viral Hepatitis and Sexually Transmitted Infections. Brasília, DF, Brazil.
Ministry of Health. Department of HIV/AIDS, Tuberculosis, Viral Hepatitis and Sexually Transmitted Infections. Brasília, DF, Brazil.
University of Brasilia. Department of Public Health. Brasília, DF, Brazil.
Oswaldo Cruz Foundation. Evandro Chagas National Institute of Infectious Diseases. Acute Febrile Illnesses Laboratory. Rio de Janeiro, RJ, Brazil.
Emerging Infectious Diseases Branch. Walter Reed Army Institute of Research. Silver Spring, MD, USA.
Oswaldo Cruz Foundation. Evandro Chagas National Institute of Infectious Diseases. Acute Febrile Illnesses Laboratory. Rio de Janeiro, RJ, Brazil.
Department of Sexual and Reproductive Health and Research. World Health Organization. Geneva, Switzerland.
Oswaldo Cruz Foundation. Oswaldo Cruz Institute. Flavivirus Laboratory. Rio de Janeiro, RJ, Brazil.
Department of Sexual and Reproductive Health and Research. World Health Organization. Geneva, Switzerland.
Tropical Medicine Foundation Doctor Heitor Vieira Dourado. Department of Malaria. Manaus, AM, Brazil / Amazonas State University. School of Health Sciences. Manaus, AM, Brazil.
Tropical Medicine Foundation Doctor Heitor Vieira Dourado. Department of Malaria. Manaus, AM, Brazil.
Oswaldo Cruz Foundation. Institute Aggeu Magalhães. Department of Virology and Experimental Therapy. Recife, PE Brazil.
Department of Sexual and Reproductive Health and Research. World Health Organization. Geneva, Switzerland.
Oswaldo Cruz Foundation. Institute Aggeu Magalhães. Department of Virology and Experimental Therapy. Recife, PE, Brazil.
Ministry of Health. Department of HIV/AIDS, Tuberculosis, Viral Hepatitis and Sexually Transmitted Infections. Brasília, DF, Brazil.
Ministry of Health. Department of HIV/AIDS, Tuberculosis, Viral Hepatitis and Sexually Transmitted Infections. Brasília, DF, Brazil.
University of Brasilia. Department of Public Health. Brasília, DF, Brazil.
Oswaldo Cruz Foundation. Evandro Chagas National Institute of Infectious Diseases. Acute Febrile Illnesses Laboratory. Rio de Janeiro, RJ, Brazil.
Emerging Infectious Diseases Branch. Walter Reed Army Institute of Research. Silver Spring, MD, USA.
Oswaldo Cruz Foundation. Evandro Chagas National Institute of Infectious Diseases. Acute Febrile Illnesses Laboratory. Rio de Janeiro, RJ, Brazil.
Department of Sexual and Reproductive Health and Research. World Health Organization. Geneva, Switzerland.
Oswaldo Cruz Foundation. Oswaldo Cruz Institute. Flavivirus Laboratory. Rio de Janeiro, RJ, Brazil.
Resumen en ingles
This study aimed to analyze the detection and duration of the Zika virus (ZIKV) in plasma, urine, saliva, sweat, rectal swabs, vaginal secretions, breast milk, and semen and to explore risk factors associated with prolonged viral persistence. A prospective cohort study of symptomatic patients and their household contacts was conducted in Brazil from July 2017 to June 2019. A total of 260 individuals (184 women and 76 men) with confirmed ZIKV infection were enrolled and followed up for 12 months. ZIKV RNA was present in all body fluid specimens and detectable for extended periods in urine, sweat, rectal swabs, and semen. The longest detection duration was found in semen, with high viral loads in the specimens. ZIKV RNA clearance was associated with several factors, including age, sex, education level, body mass index, non-purulent conjunctivitis, joint pain, and whether the participant had a history of yellow fever vaccination. The influence of each of these factors on the low or fast viral clearance varied according to the specific body fluid under investigation. Recurrent ZIKV detection events after total viral clearance were observed in the cohort. Our findings provide valuable insights into the persistence and potential recurrence of ZIKV infection, highlighting the need for continued monitoring and follow-up of individuals infected with ZIKV and for effective prevention measures to reduce the risk of transmission.
Palabras clave en ingles
ZIKV rRT‑PCR detectionZIKV persistence in body fuids
ZIKV RNA recurrent detection
Factors associated with ZIKV persistence
Compartir